Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function

Antonella Papa, Lixin Wan, Massimo Bonora, Leonardo Salmena, Min Sup Song, Robin M. Hobbs, Andrea Lunardi, Kaitlyn Webster, Christopher Ng, Ryan H. Newton, Nicholas Knoblauch, Jlenia Guarnerio, Keisuke Ito, Laurence A. Turka, Andy H. Beck, Paolo Pinton, Roderick T. Bronson, Wenyi Wei, Pier Paolo Pandolfi

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous PtenC124S/+ and PtenG129E/+ cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten+/- counterparts, whereas this difference is no longer apparent between PtenC124S/- and Pten-/- cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.

Original languageEnglish (US)
Pages (from-to)595-610
Number of pages16
JournalCell
Volume157
Issue number3
DOIs
StatePublished - Apr 24 2014

Fingerprint

PTEN Phosphohydrolase
Phosphoric Monoester Hydrolases
Conformations
Tumors
Neoplasms
Chemical activation
Display devices
Tissue
Lipids
Mutation
phosphatidylinositol 3,4,5-triphosphate

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Papa, A., Wan, L., Bonora, M., Salmena, L., Song, M. S., Hobbs, R. M., ... Pandolfi, P. P. (2014). Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell, 157(3), 595-610. https://doi.org/10.1016/j.cell.2014.03.027

Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. / Papa, Antonella; Wan, Lixin; Bonora, Massimo; Salmena, Leonardo; Song, Min Sup; Hobbs, Robin M.; Lunardi, Andrea; Webster, Kaitlyn; Ng, Christopher; Newton, Ryan H.; Knoblauch, Nicholas; Guarnerio, Jlenia; Ito, Keisuke; Turka, Laurence A.; Beck, Andy H.; Pinton, Paolo; Bronson, Roderick T.; Wei, Wenyi; Pandolfi, Pier Paolo.

In: Cell, Vol. 157, No. 3, 24.04.2014, p. 595-610.

Research output: Contribution to journalArticle

Papa, A, Wan, L, Bonora, M, Salmena, L, Song, MS, Hobbs, RM, Lunardi, A, Webster, K, Ng, C, Newton, RH, Knoblauch, N, Guarnerio, J, Ito, K, Turka, LA, Beck, AH, Pinton, P, Bronson, RT, Wei, W & Pandolfi, PP 2014, 'Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function', Cell, vol. 157, no. 3, pp. 595-610. https://doi.org/10.1016/j.cell.2014.03.027
Papa, Antonella ; Wan, Lixin ; Bonora, Massimo ; Salmena, Leonardo ; Song, Min Sup ; Hobbs, Robin M. ; Lunardi, Andrea ; Webster, Kaitlyn ; Ng, Christopher ; Newton, Ryan H. ; Knoblauch, Nicholas ; Guarnerio, Jlenia ; Ito, Keisuke ; Turka, Laurence A. ; Beck, Andy H. ; Pinton, Paolo ; Bronson, Roderick T. ; Wei, Wenyi ; Pandolfi, Pier Paolo. / Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. In: Cell. 2014 ; Vol. 157, No. 3. pp. 595-610.
@article{42ea4752261341e69d904e12ee4fdb78,
title = "Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function",
abstract = "PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous PtenC124S/+ and PtenG129E/+ cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten+/- counterparts, whereas this difference is no longer apparent between PtenC124S/- and Pten-/- cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.",
author = "Antonella Papa and Lixin Wan and Massimo Bonora and Leonardo Salmena and Song, {Min Sup} and Hobbs, {Robin M.} and Andrea Lunardi and Kaitlyn Webster and Christopher Ng and Newton, {Ryan H.} and Nicholas Knoblauch and Jlenia Guarnerio and Keisuke Ito and Turka, {Laurence A.} and Beck, {Andy H.} and Paolo Pinton and Bronson, {Roderick T.} and Wenyi Wei and Pandolfi, {Pier Paolo}",
year = "2014",
month = "4",
day = "24",
doi = "10.1016/j.cell.2014.03.027",
language = "English (US)",
volume = "157",
pages = "595--610",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function

AU - Papa, Antonella

AU - Wan, Lixin

AU - Bonora, Massimo

AU - Salmena, Leonardo

AU - Song, Min Sup

AU - Hobbs, Robin M.

AU - Lunardi, Andrea

AU - Webster, Kaitlyn

AU - Ng, Christopher

AU - Newton, Ryan H.

AU - Knoblauch, Nicholas

AU - Guarnerio, Jlenia

AU - Ito, Keisuke

AU - Turka, Laurence A.

AU - Beck, Andy H.

AU - Pinton, Paolo

AU - Bronson, Roderick T.

AU - Wei, Wenyi

AU - Pandolfi, Pier Paolo

PY - 2014/4/24

Y1 - 2014/4/24

N2 - PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous PtenC124S/+ and PtenG129E/+ cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten+/- counterparts, whereas this difference is no longer apparent between PtenC124S/- and Pten-/- cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.

AB - PTEN dysfunction plays a crucial role in the pathogenesis of hereditary and sporadic cancers. Here, we show that PTEN homodimerizes and, in this active conformation, exerts lipid phosphatase activity on PtdIns(3,4,5)P3. We demonstrate that catalytically inactive cancer-associated PTEN mutants heterodimerize with wild-type PTEN and constrain its phosphatase activity in a dominant-negative manner. To study the consequences of homo- and heterodimerization of wild-type and mutant PTEN in vivo, we generated Pten knockin mice harboring two cancer-associated PTEN mutations (PtenC124S and PtenG129E). Heterozygous PtenC124S/+ and PtenG129E/+ cells and tissues exhibit increased sensitivity to PI3-K/Akt activation compared to wild-type and Pten+/- counterparts, whereas this difference is no longer apparent between PtenC124S/- and Pten-/- cells. Notably, Pten KI mice are more tumor prone and display features reminiscent of complete Pten loss. Our findings reveal that PTEN loss and PTEN mutations are not synonymous and define a working model for the function and regulation of PTEN.

UR - http://www.scopus.com/inward/record.url?scp=84897406995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897406995&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2014.03.027

DO - 10.1016/j.cell.2014.03.027

M3 - Article

VL - 157

SP - 595

EP - 610

JO - Cell

JF - Cell

SN - 0092-8674

IS - 3

ER -